Ranitidine
- Product NDC
- 70518-2633
- 11-digit product format
- 705182633
- Labeler code
- 70518
- Product ID
- 70518-2633_cbe71da5-49e2-a7b4-e053-2995a90a2e56
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA209859
- Marketing category
- ANDA
- Marketing start
- 2020-03-17
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2633-0 | 70518263300 | 30 CAPSULE in 1 BLISTER PACK (70518-2633-0) | 30 capsule | 2020-03-17 | 0000-00-00 | No | No | Current |